Glycogen synthase kinase 3 beta has been shown to alter anxiety-, depression-, and addiction-related behaviors in rats, as well as neuronal activity in the shell of the nucleus accumbens [45]. This evidence concerns the gene GSK3B and depressive symptom measurement.